Crossmark

Gain of function variants in PCSK9 gene in high risk patients after myocardial infarction with increased lipoprotein (a) values and treated with statins

Crossref DOI link: https://doi.org/10.1038/s41598-025-12432-6

Published Online: 2025-07-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ugovšek, Sabina https://orcid.org/0000-0002-2056-4781
Likozar, Andreja Rehberger

Levstek, Tina

Podkrajšek, Katarina Trebušak

Zupan, Janja

Antonić, Slobodan

Šebeštjen, Miran
License Information

Text and Data Mining valid from 2025-07-23

Version of Record valid from 2025-07-23
More Information

Article History

Received: 6 April 2025

Accepted: 17 July 2025

First Online: 23 July 2025

Declarations

:

: The authors declare no competing interests.

: The study was conducted in accordance with the Declaration of Helsinki and approved by the Slovenian Ethics Committee for Research in Medicine (KME 0120-357/2018/8; date of approval: 23 April 2019 and KME 0120-317/2021/3; date of approval: 2 August 2021).

: Informed consent was obtained from all subjects involved in the study.

Document is current

Any future updates will be listed below